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ABSTRACT
The mammalian mitochondrial genome contains a
single tRNAMet gene that gives rise to the initiator
and elongator tRNAMet. It is generally believed that
mitochondrial protein synthesis begins with formyl-
methionyl-tRNA, which indicates that the formylation
of mitochondrial Met-tRNA specifies its participation
in initiation through its interaction with initiation
factor 2 (IF-2). However, recent studies in yeast mito-
chondria, suggest that formylation is not required for
protein synthesis. In addition, bovine IF-2mt could
replace yeast IF-2mt in strains that lack fMet-tRNA
which suggests that this paradigm may extend to
mammalian mitochondria. Here, the importance of
the formylation of mitochondrial Met-tRNA for the
interaction with IF-2mt was investigated by measuring
the ability of bovine IF-2mt to bind mitochondrial fMet-
tRNA. In direct binding experiments, bovine IF-2mt has
a 25-fold greater affinity for mitochondrial fMet-tRNA
than Met-tRNA, using either the native mitochondrial
tRNAMet or an in vitro transcript of bovine mitochon-
drial tRNAMet. In addition, IF-2mt will not effectively
stimulate mitochondrial Met-tRNA binding to mito-
chondrial ribosomes, exhibiting a 50-fold preference
for fMet-tRNA over Met-tRNA in this assay. Finally, the
region of IF-2mt responsible for the interaction with
fMet-tRNA was mapped to the C2 sub-domain of
domain VI of this factor.
INTRODUCTION
Of the 22 tRNAs encoded in mammalian mitochondrial DNA,
there is a single tRNA that represents each amino acid, except
for tRNASer and tRNALeu, which have 2 isoacceptors each. In
mammals, there is no evidence of tRNA import into mitochon-
dria, hence these species represent the complete set of tRNAs
available for the translational apparatus. The presence of a
single species of tRNAMet is quite unusual. Prokaryotic and
eukaryotic cytoplasmic translational systems use two tRNAMet
species, one designated for initiation and one for elongation.
Even the mitochondria of most lower eukaryotes possess two
specialized tRNAMet species. The mammalian mitochondrial
translational system, therefore, must have a unique mechanism
by which this single tRNAMet species is partitioned between
the initiation and elongation phases of protein synthesis. In
addition to the single tRNAMet species, mitochondria possess
an alternate genetic code in which both AUG and AUA code
for methionine (1). A novel modification (5-formyl cytidine)
in the first position of the anticodon in tRNAMet may give rise
to its ability to decode both AUG and AUA (2,3).
Translational initiation in prokaryotes and mammalian
mitochondria generally occurs with fMet-tRNA (4). The
gene that encodes the bovine mitochondrial methionyl-
tRNA transformylase (MTFmt) has been cloned and the protein
has been studied biochemically (5–7). The partitioning of
tRNAMet into either the initiation phase or the elongation
phase of protein synthesis is assumed to occur by a competi-
tion between MTFmt and mitochondrial elongation factor Tu
(EF-Tumt) for the Met-tRNA
Met (6). Once Met-tRNAMet is
formylated by MTFmt, it becomes a substrate for mitochon-
drial initiation factor 2 (IF-2mt) and participates in the initia-
tion phase of protein synthesis. However, if Met-tRNA binds
to EF-Tumt:GTP before it is formylated, it acts as an elongator
tRNA. This partitioning mechanism requires that IF-2mt
strongly discriminates against Met-tRNAMet and that EF-
Tumt preferentially binds Met-tRNA
Met. For bovine IF-2mt,
a strong preference for fMet-tRNA has been demonstrated
using both the yeast and Escherichia coli initiator tRNAMet
species (8). It has also been shown that EF-Tumt strongly
discriminates against E.coli fMet-tRNAf
Met (9). Taken
together, these observations suggest that the formylation of
mitochondrial tRNAMet governs its identity as either an initia-
tor or an elongator tRNAMet.
Recently, however, studies in yeast mitochondria have
suggested that formylation of Met-tRNA is not required for
mitochondrial protein synthesis. Yeast mutants that lacked the
ability to formylate the mitochondrial initiator Met-tRNA
had normal protein synthesis, which indicates that formylation
is not essential for mitochondrial translation in yeast (10).
Further, bovine IF-2mt, at least, when over-expressed in
yeast, can support translation in the yeast mitochondria
that lacks the ability to formylate Met-tRNAMet (11). These
data prompted the suggestion that formylation of Met-tRNA
may not be required for translation in mammalian mito-
chondria. To further understand the role of formylation of
Met-tRNA in the yeast mitochondria, yeast IF-2mt was cloned
and characterized biochemically (12). In contrast to previous
studies on bovine IF-2mt, yeast IF-2mt showed a small but
significant degree of binding to Met-tRNAMet (12). These
observations support the in vivo findings that formylation of
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initiator tRNA is not essential in the yeast mitochondrial
translational system.
Here, we have investigated the interaction of bovine IF-2mt
with mitochondrial fMet-tRNA to determine the role of




The chemicals were purchased from Fisher Scientific or
Sigma. [35S]Met was obtained from Perkin Elmer Life Science
Products. SUPERaseInTM RNase inhibitor was purchased
from Ambion. Pyruvate kinase and folinic acid were from
Sigma. E.coli tRNA was purchased from Roche. E.coli
tRNAf
Met was partially purified from crude E.coli tRNA as
described previously (13). The bovine mitochondrial tRNAMet
(mtRNAMet) transcript and human mitochondrial methionyl-
tRNA synthetase (MetRSmt) were purified as described
previously (14). Crude bovine mitochondrial tRNA was kindly
provided by Senyene Eyo Hunter (University of North
Carolina at Chapel Hill). IF-2mt and various N- or C-terminal
truncated derivatives were expressed and purified as described
by A. Spencer and L. Spremulli (submitted for publication).
Mitochondrial initiation factor 3 (IF-3mt) was kindly provided
by Dr Emine Koc (University of North Carolina at Chapel
Hill). Bovine liver mitochondria, 55S ribosomes and 28S
subunits were prepared as described previously (15,16).
Expression and purification of bovine MTFmt
A plasmid containing the cDNA for bovine MTFmt was kindly
provided by Dr Kimitsuna Watanabe (University of Tokyo).
The DNA was transformed into E.coli BL21(DE3)pLysS cells
(Stratagene) for expression. A single colony of cells that har-
bored the pET15-bovine MTFmt construct was used to inocu-
late 10 ml of 2YT media (17) that contained 50 mg/ml of
ampicillin. This culture was grown at 37C to saturation
and was used to inoculate 2 l of 2YT media (2 · 1 l),
which were grown at 37C to an A600 of 0.6–0.8. The expres-
sion of bovine MTFmt was induced by the addition of 140 mM
isopropyl-b-D-thiogalactopyranoside. Expression was carried
out at 18C for 16 h on a rotary shaker at 150 r.p.m. Following
expression, cells were harvested, resuspended in a volume of
at least 100 ml of buffer containing 50 mM Tris–HCl (pH 7.6)
and pelleted by low speed centrifugation (4000 g for 30 min at
4C). At this point, cells were either fast-frozen and stored at
70C until future use or treated as described below.
Cell pellets (9 g) were resuspended in Buffer 1 [50 mM
Tris–HCl (pH 7.6), 500 mM KCl, 5 mM MgCl2, 10 mM
imidazole, 3 mM 2-mercaptoethanol (BME) and 0.1 mM phe-
nylmethylsulfonyl fluoride] at a ratio of 10 ml/g cell weight
and sonicated at 60 W on ice using 1 s bursts with 4 s cooling
periods for 12 min (performed in 3 min intervals). DNase I
(5 mg/ml) was added and the lysate was subjected to centrifuga-
tion at 38 000 r.p.m. in a Beckman Type 60 rotor for 1 h at 4C.
Following centrifugation, 1.0 ml of Ni-NTA resin (50%
slurry in Buffer 1) was added to the supernatant and incubation
was carried out at 4C for 1 h with rocking. The sample was
transferred to a polypropylene column and the resin was
subsequently washed with 100 ml Buffer 1. Bovine
MTFmt was eluted from the Ni-NTA resin with Buffer 1
containing 220 mM imidazole for 20 min at 4C. The elution
was repeated twice and all eluates were combined before
dialyzing the sample against 250 ml of Buffer 2 [20 mM
Tris–HCl (pH 7.6), 3 mM BME, 100 mM KCl and 10%
glycerol] for 45 min at 4C with one change of buffer and
an additional 45 min of dialysis. This preparation gave a major
band on SDS–PAGE with an apparent molecular weight of
40 kDa and was estimated to be at least 50% pure by
Coomassie staining. The sample was used without further
purification since it was active and free of nuclease contam-
ination (data not shown).
Preparation of Met-tRNAMet
The large-scale aminoacylation of partially purified
E.coli tRNAf
Met was carried out essentially as described
(18).The large-scale aminoacylation of a bovine mitochondrial
tRNAMet transcript was carried out in a reaction (1 ml) con-
taining 50 mM Tris–HCl (pH 7.8), 2.5 mM MgCl2, 2.5 mM
ATP, 0.2 mM spermine, 0.2 mg/ml BSA, 8 mM [35S]Met
(15 000 c.p.m./pmol), 260 mg of partially purified human
MetRSmt, 100 U SUPERaseIn
TM and 300 pmol of the bovine
mtRNAMet transcript. The reaction was incubated at 37C for
30 min and the tRNA was purified by two extractions with
phenol and one extraction with chloroform. The tRNA was
precipitated with ethanol overnight at 20C and resuspended
in 10 mM potassium succinate (pH 6.0). The large-scale
aminoacylation of native bovine mtRNAMet was carried out
as described above except that the reaction mixtures contained
120 mg of human MetRSmt and 190 mg of crude native bovine
mitochondrial tRNA.
Formylation activity of bovine MTFmt
Folinic acid (6.4 mg) was dissolved in 1 ml of 100 mM HCl
containing 5 mM DTT and incubated in the dark, at room
temperature, for 12 h. The sample was diluted to 10 ml
with distilled H2O to a final concentration of 1.25 mM. The
ability of bovine MTFmt to formylate Met-tRNA was moni-
tored using thin layer chromatography (TLC). Formylation
reactions (10 ml) contained 20 mM Tris–HCl (pH 7.6),
0.1 mM EDTA, 150 mM KCl, 7 mM MgCl2, 10 mM BME,
10 pmol (1 mM) E.coli [35S]Met-tRNAfMet (5000 c.p.m./
pmol), 1 mg of partially purified bovine MTFmt and, where
indicated, 0.125 mM folinic acid. Following incubation at
37C for 10 min, 0.5 M NaOH was added to a final
concentration of 0.1 M and incubation was continued at
37C for 30 min. Approximately one-tenth of the reaction
mixture was spotted on a Whatman LK2 TLC plate that
had previously been run with distilled H2O and dried. The
mobile phase for TLC analysis was butanol/acetic acid/H2O
(4:1:1). The plate was dried and placed on a phosphor
screen for at least 12 h. The [35S]fMet was visualized by
phosphorimaging with a Molecular Dynamics’ Storm 840.
To measure the ability of MTFmt to formylate either a
bovine mitochondrial Met-tRNAMet transcript or native
bovine mitochondrial Met-tRNAMet, the formylation reaction
was carried out as described above except that it contained
6 pmol (0.6 mM) [35S]Met-tRNAMet (5000 c.p.m./pmol)
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transcript or 1.5 pmol (0.15 mM) of native mitochondrial
[35S]Met-tRNAMet (15 000 c.p.m./pmol).
Preparation of mitochondrial fMet-tRNAMet
Large-scale charging and formylation of mitochondrial
tRNAMet was performed in a coupled assay essentially as
described above for the aminoacylation of mtRNAMet with
the following modifications. Reaction mixtures (1 ml) con-
tained 50 mM Tris–HCl (pH 7.8), 2.5 mM MgCl2, 2.5 mM
ATP, 0.2 mM spermine, 0.2 mg/ml BSA, 8 mM [35S]Met
(15 000 c.p.m./pmol), 100 U SUPERaseInTM, 0.125 mM
folinic acid, 340 mg of partially purified human MetRSmt,
50 mg of partially purified bovine MTFmt and 300 pmol of
the bovine mtRNAMet transcript. For large-scale aminoacyla-
tion and formylation of the native bovine mtRNAMet, reaction
mixtures (1 ml) were prepared as described above except that
they contained 120 mg of partially purified human MetRSmt
and 210 mg of crude native mitochondrial tRNA. The reaction
mixtures were incubated at 37C for 30 min and the tRNA was
purified from the reaction components as described above.
Following purification of the tRNA, an aliquot of the products
was analyzed for formylation by using the TLC procedure.
Interaction of bovine IF-2mt with mitochondrial
fMet-tRNAMet
The RNase protection assays were carried out essentially as
described (19). Reaction mixtures (25 ml) contained 50 mM
Tris–HCl (pH 7.8), 2 mM DTT, 7 mM MgCl2, 100 mM
NH4Cl, 0.25 mM guanosine 5
0-[b,g-imido]triphosphate
(GDPNP), 2 pmol (0.08 mM) bovine mitochondrial
[35S]fMet-tRNAMet transcript or native bovine mitochondrial
[35S]fMet-tRNAMet (15 000 c.p.m./pmol) and the indicated
amounts of the mature form of IF-2mt (typically 2.8–
10 mM). Following incubation at 0C for 15 min, 5 mg of
RNase A was added. Incubation was continued for an addi-
tional 30 s at 0C. The reaction was terminated by the addition
of 3 ml of ice-cold 5% trichloroacetic acid (TCA). Incubation
at 0C was continued for 10 min. The precipitate formed was
collected on nitrocellulose filters which were washed with 2 ·
3 ml cold 5% TCA and dried for 6 min at 100C. The amount
of [35S]fMet-tRNA remaining was determined by scintillation
counting. A blank representing the amount of [35S]fMet-tRNA
that remained in the absence of IF-2mt was subtracted from
each point (generally <0.1 pmol).
The ability of various derivatives of IF-2mt to bind mito-
chondrial [35S]fMet-tRNA was measured as described above
using 3 pmol (0.12 mM) bovine mitochondrial [35S]fMet-
tRNA transcript and 0.6–1.2 mM of each derivative. For direct
comparison of each derivative, the ability of 1.0 mM of each
IF-2mt derivative to protect 2.5 pmol (0.1 mM) of the bovine
mitochondrial [35S]fMet-tRNA transcript was measured. The
remainder of the assay was carried out as described above.
Initiation complex formation on mitochondrial
ribosomes with mitochondrial fMet-tRNAMet
The ability of IF-2mt to stimulate the binding of mitochondrial
[35S]fMet-tRNA to 28S subunits was measured in an in vitro
binding assay essentially as described previously (8,20).
Reaction mixtures (50 ml) contained 50 mM Tris–HCl (pH
7.6), 1 mM DTT, 0.1 mM spermine, 35 mM KCl, 7.5 mM
MgCl2, 0.25 mM GDPNP, 5 mg poly(A,U,G), 10 U SUPERase
InTM, 2.5 pmol (0.05 mM) 28S subunits, 0.13–3 pmol
(2.6–60 nM) of mitochondrial [35S]fMet-tRNA (15 000 c.p.m./
pmol) and the indicated amounts of IF-2mt (3–7 pmol, 0.06–
0.14 mM). Following incubation of the reactions at 27C for
20 min, 3 ml of ice-cold buffer [50 mM Tris–HCl (pH 7.6),
35 mM KCl and 7.5 mM MgCl2] was added and the reactions
were filtered through a nitrocellulose membrane (Millipore
type HA). Each filter was washed twice with 3 ml of the
above buffer and dried at 100C for 6 min. The amount of
[35S]fMet-tRNA bound to the ribosome was determined by
liquid scintillation counting. A blank representing the amount
of [35S]fMet-tRNA that bound to the 28S subunit in the
absence of IF-2mt at each concentration of fMet-tRNA was
subtracted from each value (0.01–0.03 pmol).
The ability of IF-2mt to promote the binding of mitochon-
drial fMet-tRNA to mitochondrial 55S ribosomes was carried
out essentially as described above, except that reaction mix-
tures (50 ml) contained 50 mM Tris–HCl (pH 7.6), 1 mM DTT,
0.1 mM spermine, 35 mM KCl, 7.5 mM MgCl2, 0.25 mM
GTP, 1.25 mM phosphoenolpyruvate (PEP), 0.5 U pyruvate
kinase, 5 mg poly(A,U,G), 10 U SUPERaseInTM, 20 pmol
(0.4 mM) mitochondrial IF-3, 3.0–3.5 pmol (0.06–0.07 mM)
55S ribosomes, 0.125–1.5 pmol (2.5–30 nM) of either native
or the transcript of bovine mitochondrial [35S]fMet-tRNA
(15 000 c.p.m./pmol) and the indicated amounts of IF-2mt
(4–14 pmol, 0.08–0.28 mM). The reactions were incubated
at 27C for 20 min and treated as described above. A blank
representing the amount of [35S]fMet-tRNA binding to the 55S
ribosome in the absence of IF-2mt (0.01–0.04 pmol) at each
concentration of fMet-tRNA has been subtracted from
each value.
RESULTS
Ability of bovine MTFmt to formylate mitochondrial
tRNAMet
The ability of bovine MTFmt to formylate various Met-
tRNAMet substrates was tested to assess whether the enzyme
was active with the transcript of the tRNAMet gene as well as
with the native tRNA. Following the reaction, the ester bond
on the tRNA was hydrolyzed by NaOH, releasing the radi-
olabeled amino acid that was analyzed for formylation by
TLC, which clearly separates Met and fMet. The primary
determinant for substrate recognition by bovine MTFmt is
the amino acid methionine, and previous studies have
shown that E.coli Met-tRNAf
Met is efficiently formylated by
the mitochondrial enzyme (6,7). E.coli Met-tRNA was initi-
ally used to test the experimental approach for monitoring the
formylation reaction, before using the mitochondrial Met-
tRNA. As expected, bovine MTFmt efficiently formylated
the heterologous E.coli Met-tRNAf
Met substrate in the pre-
sence of the formyl group donor (Figure 1, lanes 1 and 2)
(7). Yeast [35S]fMet-tRNA was used as a control for the loca-
tion of fMet in these experiments and contains a small amount
of methionine oxidation products that have a lower Rf value
than methionine (Figure 1, lane 3). In the presence of the
formyl group donor, bovine MTFmt effectively formylated
the in vitro transcript of mitochondrial Met-tRNAMet (Figure 1,
lanes 4 and 5) and the native mitochondrial Met-tRNAMet
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(Figure 1, lanes 6 and 7). Under the conditions used, close
to 100% of the mitochondrial Met-tRNA could be formylated.
Interaction of IF-2mt with mitochondrial fMet-tRNA
Met
The ability of bovine IF-2mt to bind formylated and unformyl-
ated Met-tRNA in solution was assessed by measuring the
amount of fMet-tRNA protected from hydrolysis by RNase
A in the presence of increasing amounts of IF-2mt. The
binding of fMet-tRNA and Met-tRNA to bovine IF-2mt
was determined both for the in vitro transcript and for
the native bovine mitochondrial fMet-tRNAMet. Bovine
IF-2mt clearly has a much higher affinity for fMet-tRNA
Met
and discriminates against Met-tRNA when either the
transcript or the native mitochondrial tRNAMet is used
(Figure 2). The amount of protection achieved with the tran-
script is slightly higher than that obtained with the native fMet-
tRNAMet, which indicates that the modified nucleotides
present in the native bovine mtRNAMet do not play a role
in the recognition of mitochondrial fMet-tRNAMet by bovine
IF-2mt. These modifications include two pseudouridines and
the f5C that is located in the first position of the anticodon. The
lower degree of binding to the native mitochondrial fMet-
tRNAMet could also indicate that the presence of a large excess
of non-specific mitochondrial tRNA interferes with the bind-
ing to IF-2mt. Nonetheless, the binding of mitochondrial fMet-
tRNA to bovine IF-2mt was at least 50-fold greater than the
binding observed with mitochondrial Met-tRNA.
The strong preference of IF-2mt for fMet-tRNA contrasts
with the weaker, 4-fold, preference for fMet-tRNA observed
with yeast IF-2mt (12). This measurement, however, was
done in a filter binding assay in the absence of magnesium
and may not reflect a biologically relevant interaction (12).
Similar to bovine IF-2mt, yeast IF-2mt did not protect
the unformylated Met-tRNA in a RNase protection assay
(12). It should also be noted that GDPNP did not affect
the binding of fMet-tRNA to bovine IF-2mt. The same
observation was made for the interaction of E.coli IF-2
with fMet-tRNA (21).
Bovine IF-2mt is organized into four domains and contains
the equivalent of domains III–VI of E.coli IF-2 (Figure 3A)
(22). To determine the domain(s) of bovine IF-2mt involved in
the interaction with mitochondrial fMet-tRNA, the ability of
a number of IF-2mt derivatives truncated at the N- and/or
C-terminus to bind mitochondrial fMet-tRNA was measured
in the RNase protection assay. Initially, the ability of the
Figure 1. TLC analysis of the formylation of Met-tRNA by bovine MTFmt.
Formylation reactions contained bovine MTFmt and either E.coli [
35S]Met-
tRNA or mitochondrial [35S]Met-tRNA as indicated. The numbers in
parentheses indicate the amount applied in each lane in the TLC analysis.
Lane 1: E.coli [35S]Met-tRNA (1 pmol) in the absence of a formyl group
donor. Lane 2: E.coli [35S]Met-tRNA (1 pmol) in the presence of a formyl
group donor. Lane 3: yeast [35S]fMet-tRNA (1 pmol) prepared as described in
(18) as a marker for fMet. Lane 4: mitochondrial [35S]Met-tRNA transcript
(1 pmol) in the absence of a formyl group donor. Lane 5: mitochondrial
[35S]Met-tRNA transcript (1 pmol) in the presence of a formyl group donor.
Lane 6: native mitochondrial [35S]Met-tRNA (0.2 pmol) in the absence of a
formyl group donor. Lane 7: native mitochondrial [35S]Met-tRNA (0.2 pmol) in
the presence of a formyl group donor.
Figure 2. Interaction of bovine IF-2mt with mitochondrial fMet-tRNA. The ability of bovine IF-2mt to protect mitochondrial fMet-tRNA from hydrolysis by RNase A
was measured as described in Materials and Methods. A blank representing the amount of [35S]fMet-tRNA that remained in the absence of IF-2mt was subtracted from
each point. Data were fit by linear least-squares analysis. (A) Protection assays contained 2 pmol of either mitochondrial [35S]fMet-tRNA transcript (closed circles) or
2 pmol of mitochondrial [35S]Met-tRNA transcript (open circles) and the indicated amounts of IF-2mt. (B) Protection assays contained 2 pmol of either native
mitochondrial [35S]fMet-tRNA (closed circles) or 2 pmol native mitochondrial [35S]Met-tRNA (open circles) and the indicated amounts of IF-2mt.
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various derivatives to protect fMet-tRNA was determined for
several concentrations of IF-2mt. The protection of [
35S]fMet-
tRNA was linear for each derivative over the concentration
range tested (0.6–1.2 mM) (data not shown). To simplify the
analysis, the ability of each derivative to bind mitochondrial
fMet-tRNA was measured at a single concentration of IF-2mt
(1.0 mM) (Figure 3B). There was no significant difference in
the ability of either the domains III–VI or the domains IV–VI
derivative to bind fMet-tRNA (Figure 3B). Thus, domain III
does not appear to play a role in the binding of fMet-tRNA to
IF-2mt. Removal of domain IV, however, caused a 40% reduc-
tion in the ability of IF-2mt to bind fMet-tRNA. The isolated
domain VI alone was capable of binding fMet-tRNA
(Figure 3B), although it was somewhat less active than the
full-length factor. The decrease in binding observed in both the
domains V and VI, and domain VI derivatives does not imply a
direct role of domain IV in the interaction with fMet-
tRNA, but presumably reflects the influence of domain IV
on the overall conformation of IF-2mt (A.C. Spencer and
L.L. Spremulli, unpublished data). Both derivatives lacking
the C2 sub-domain of domain VI (domains III–V and domains
III–VI C1) were completely inactive in binding fMet-tRNA.
Thus, it appears that domain VI of IF-2mt is responsible for the
interaction of IF-2mt with fMet-tRNA. These data indicate
that, like prokaryotic IF-2, domain VI C2 is directly
responsible for the interaction with fMet-tRNA (23–26).
Initiation complex formation on mitochondrial
ribosomes with mitochondrial fMet-tRNA
The ability of bovine IF-2mt to stimulate the binding of mito-
chondrial fMet-tRNA to mitochondrial 28S subunits was mea-
sured in the presence of poly(A,U,G) and a non-hydrolyzable
analogue of GTP, GDPNP (Figure 4). In the context of the
small ribosomal subunit and the synthetic mRNA, bovine
IF-2mt prefers the formylated mitochondrial Met-tRNA tran-
script up to 10-fold over the unformylated Met-tRNA
(Figure 4A). Similarly, there is also a clear discrimination
of the native mitochondrial fMet-tRNA over the native
Met-tRNA by bovine IF-2mt in the context of 28S subunits
(Figure 4B). Bovine IF-2mt prefers the native mitochondrial
fMet-tRNA over Met-tRNA by 25-fold. When assayed on
E.coli 30S subunits, yeast IF-2mt showed only a 6- to7-fold
preference for fMet-tRNA over Met-tRNA (12).
The ability of bovine IF-2mt to stimulate fMet-tRNA
binding to mitochondrial 55S ribosomes was measured in
the presence of poly(A,U,G), GTP and mitochondrial IF-3
(Figure 5). Again, bovine IF-2mt clearly prefers both the
transcript and the native mitochondrial fMet-tRNAMet by
20-fold and 50-fold, respectively (Figure 5A and B).
DISCUSSION
In contrast to recent studies in yeast mitochondria, it is clear
that bovine IF-2mt strongly prefers mitochondrial fMet-tRNA
over Met-tRNA. These observations support the idea that pro-
tein synthesis in mammalian mitochondria does in fact involve
fMet-tRNA. Earlier support of this idea comes from the
analysis of the N-terminal amino acid of mitochondrially
synthesized proteins, which were found to contain formyl-
methionine, as well as the requirement of N10-formyl
tetrahydrofolate for mitochondrial protein synthesis (4,10).
In addition, the discovery of Met-tRNA transformylase
activity in bovine mitochondria gave further support to the
belief that fMet-tRNA initiates mitochondrial protein
synthesis, as it does in prokaryotic systems (6).
The observations made here are in contrast to those made
in vivo in yeast where it has been observed that bovine
IF-2mt can support protein synthesis in the absence of for-
mylated Met-tRNA (11). One explanation for this apparent
discrepancy is that bovine IF-2mt was over-expressed in
these cells that perhaps compensated for its low affinity
for Met-tRNA. A similar increase in the levels of IF-2
was observed in an E.coli mutant capable of initiating pro-
tein synthesis without formylated initiator tRNA (27,28).
However, at physiological levels of IF-2mt, the pathway
of translational initiation in mitochondria would occur via
fMet-tRNA.
Biochemical data on bacterial IF-2 emphasizes the
importance of the formyl group for the recognition of the
initiator tRNA by IF-2. Bacterial IF-2 selects the initiator
tRNA to a significant extent on the basis of the fMet moiety
(29,30). Studies on Thermus thermophilus IF-2 also showed
that fMet-AMP could be used as a minimal substrate for IF-2
(24). A portion of IF-2, the C2 sub-domain (Figure 3A), binds
Figure 3. Binding of various IF-2mt derivatives to mitochondrial fMet-tRNA.
(A) Domain organization of bovine IF-2mt and the derivatives used to determine
the domain(s) of IF-2mt responsible for the interaction with fMet-tRNA. The
domains have been assigned based on the E.coli IF-2 nomenclature (22) and
the amino acid residues that encompasses each domain are indicated. (B) The
relative percentage of fMet-tRNA protected was calculated based on the
amount of [35S]fMet-tRNA (2.5 pmol input, 0.1 mM) protected by 1.0 mM
of each derivative. The percentage of fMet-tRNA protected by the full-
length IF-2mt was set at 100% (5% of input tRNA) to facilitate
comparison. The amount of [35S]fMet-tRNA that remained in the absence
of IF-2mt has been subtracted from each value (0.05 pmol).
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fMet-tRNA with the same affinity as full-length IF-2 (25).
The structure of the C2 sub-domain of domain VI of
Bacillus stearothermophilus IF-2 has been solved using
NMR (31) and folds into a b-barrel similar to domain II
of EF-Tu. The combination of structural information and
mutagenesis data on residues near the surface of IF-2
contributed to the mapping of the binding site for
fMet-tRNA on IF-2 (32). Several conserved amino acid
residues in B.stearothermophilus IF-2 are important for
fMet-tRNA binding (32). These include Arg-700 which
lies close to the formyl group, Lys-699 and Lys-702 which
are necessary for fMet-tRNA binding and Cys-668 and
Gly-715 which are thought to create a groove to accommodate
the Met side chain (32). The majority of these residues are
conserved in IF-2mt indicating a commonality in the
preferential binding to fMet-tRNA for both bacterial and
mitochondrial IF-2.
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